Home Newsfeeds Hess Executive Says Board To Give ‘Strong Consideration’ To Increasing Dividend This Quarter

Hess Executive Says Board To Give ‘Strong Consideration’ To Increasing Dividend This Quarter

-Reuters

byBenzinga Newsdesk

January 25, 2023

1 minute read

-Reuters

Traws Pharma Completes First Cohort Dosed In Phase 1 Trial For COVID Therapy

By Benzinga Newsdesk

May 7, 8:09 AM

Investigational travatrelvir demonstrated preclinical activity against multiple SARS-CoV-2 variants Orally administered novel protease inhibitor does not require ritonavir co-administrationFirst-in-Human study to

TRAW

Cathie Wood Stays Firm On Tesla With $4M Buy Even As Stock Slips Below Key Level — Also Loads Up On These 2 Crypto Stocks

By Bhavik Nair

December 20, 1:53 AM

Cathie Wood-led ARK Investment Management continued buying Tesla Inc (NASDAQ:

BTC

Watching Bausch Health Companies; Seeking Alpha Reports, Court Ruling In Patent Dispute With Norwich Pharma; Court Issued An Order Denying Norwich’s Motion To Modify Judgment In The Case Of: “Salix Pharmaceuticals, Ltd. Norwich Pharmaceuticals, Inc.”

By Happy Mohamed

May 17, 12:57 PM

https://seekingalpha.com/news/3972676-bausch-health-soars-after-court-ruling-in-patent-dispute-with-norwich-pharma?utm_campaign=twitter_automated&utm_content=news&utm_medium=social&utm_source=twitter_automated Bausch Health (NYSE:BHC) soared 40% after a court ruling related to the company’s patent suit vs Norwich Pharma over…

BHC

BriaCell Announces End Of Phase II Meeting With FDA For Bria-IMT Combination In Advanced Metastatic Breast Cancer; FDA Has Agreed On Primary Endpoint

By Bill Haddad

January 18, 9:49 AM

BriaCell has received agreement and positive feedback from its End of Phase II meeting with the FDA for lead clinical candidate, Bria-IMT™ in combination with a checkpoint inhibitor, in advanced metastatic breast

BCTX

Hess Executive Says Board To Give ‘Strong Consideration’ To Increasing Dividend This Quarter

Related Posts

Traws Pharma Completes First Cohort Dosed In Phase 1 Trial For COVID Therapy

Cathie Wood Stays Firm On Tesla With $4M Buy Even As Stock Slips Below Key Level — Also Loads Up On These 2 Crypto Stocks

Watching Bausch Health Companies; Seeking Alpha Reports, Court Ruling In Patent Dispute With Norwich Pharma; Court Issued An Order Denying Norwich’s Motion To Modify Judgment In The Case Of: “Salix Pharmaceuticals, Ltd. Norwich Pharmaceuticals, Inc.”

BriaCell Announces End Of Phase II Meeting With FDA For Bria-IMT Combination In Advanced Metastatic Breast Cancer; FDA Has Agreed On Primary Endpoint